LRMR

Larimar Therapeutics Inc

May 15 • 04:00PM ET

3.58

-0.31 -7.97 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CTNM ABEO MREO SLNO COGT

| Held by: VTI IWM VXF FESM IWN IBB DFAS VTWO VFMO IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.08	Insider Own	51.76%	Shs Outstand	103.88M	Perf Week	-9.82%
Market Cap	371.90M	Forward P/E	-	EPS next Y	-1.27	Insider Trans	10.50%	Shs Float	50.23M	Perf Month	-24.15%
Enterprise Value	175.30M	PEG	-	EPS next Q	-0.40	Inst Own	44.24%	Short Float	16.54%	Perf Quarter	13.65%
Income	-166.00M	P/S	-	EPS this Y	26.52%	Inst Trans	-13.73%	Short Ratio	1.90	Perf Half Y	6.23%
Sales	0.00M	P/B	2.36	EPS next Y	23.58%	ROA	-87.67%	Short Interest	8.31M	Perf YTD	-6.04%
Book/sh	1.52	P/C	1.86	EPS next 5Y	35.69%	ROE	-109.83%	52W High	6.42 -44.24%	Perf Year	91.44%
Cash/sh	1.93	P/FCF	-	EPS past 3/5Y	-18.15% 8.74%	ROIC	-103.27%	52W Low	1.73 106.94%	Perf 3Y	-0.28%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.70% 6.49%	Perf 5Y	-73.22%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-39.31%	Oper. Margin	-	ATR (14)	0.29	Perf 10Y	-95.47%
Dividend Ex-Date	-	Quick Ratio	2.19	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	30.91	Recom	1.11
Dividend Gr. 3/5Y	- -	Current Ratio	4.29	EPS Q/Q	28.33%	SMA20	-15.07%	Beta	0.88	Target Price	15.88
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	-21.67%	Rel Volume	0.80	Prev Close	3.89
Employees	71	LT Debt/Eq	0.02	Earnings	May 14 BMO	SMA200	-11.00%	Avg Volume	4.37M	Price	3.58
IPO	Jun 19, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	42.00% -	Trades		Volume	3,491,764	Change	-7.97%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)